The Third International Forum on long-term and sustained release new drug research and development opened in Changsha

On November 15, the third international long-term sustained release new drug R & D Summit Forum and 2019 Hunan Pharmaceutical raw and auxiliary materials Industrial Park (Changsha) investment cooperation forum hosted by the people's Government of Wangcheng District of Changsha City and Changsha biomedical industry chain promotion office and hosted by Hunan Huateng Pharmaceutical Co., Ltd opened in Changsha Purui hotel With the theme of "sharing innovation achievements and promoting industrial integration", leaders of Changsha Municipal and district governments, top experts and scholars in biomedical field at home and abroad, leaders of well-known pharmaceutical enterprises and industry elites gathered in Changsha to discuss the transformation of new drug R & D innovation achievements and seek the way of new drug industrialization development, so as to inject a strong country into the development of Changsha and national biomedical industry International kinetic energy Xi Zhenfeng, academician of the Chinese Academy of Sciences and professor of Peking University, Zhou Qilin, academician of the Chinese Academy of Sciences and professor of Nankai University, served as the honorary chairman of the meeting, and Xi Zhen, a Yangtze River scholar and professor of Nankai University, served as the chairman of the meeting The opening ceremony of the meeting was presided over by she Haoyu, member of the Party Working Committee and deputy director of the Management Committee of Wangcheng economic development zone She Haoyu, on behalf of the Organizing Committee of the conference, extended a warm welcome and sincere thanks to all the guests present △ presided over by she Haoyu, member of the Party Working Committee and deputy director of the Management Committee of Wangcheng Economic Development Zone Later, Zhou Jian, Secretary of the Party Working Committee of Wangcheng Economic Development Zone, Deng Zeping, chairman of Hunan Huateng Pharmaceutical Co., Ltd., Wang Guohai, deputy director of the Standing Committee of Changsha Municipal People's Congress and head of Changsha biomedical industry chain, Xi Zhenfeng, a Changjiang Scholar and professor of Nankai University, academician of Chinese Academy of Sciences and professor of Beijing University, addressed the conference respectively △ speech by Zhou Jian, Secretary of the Party Working Committee of Wangcheng Economic Development Zone △ speech by Deng Zeping, chairman of Hunan Huateng Pharmaceutical Co., Ltd △ speech by Wang Guohai, deputy director of the Standing Committee of Changsha Municipal People's Congress and head of Changsha biomedical industry chain △ speech by Xi Zhenzhi, a Yangtze River scholar and professor of Nankai University △ Xi Zhenfeng, academician of the Chinese Academy of Sciences and professor of Peking University, delivered a speech at the forum, which was also supported by Changsha Municipal People's government, Hunan Provincial Committee of China Zhi Gong Party and other departments and leaders at all levels To promote the development of Hunan medical raw and auxiliary materials industrial park by introducing talents, the aim is to build a medical raw and auxiliary materials industry cluster integrating medical research and development, incubation and production At the opening ceremony, huanwangmin, a deputy county-level cadre of Wangcheng Economic Development Zone, introduced the project of Hunan Pharmaceutical raw and auxiliary materials Industrial Park, introduced the layout and advantages of the industrial park to the guests, and attracted the attention of many pharmaceutical enterprises △ at the opening ceremony of the speech by Huan Wangmin, deputy county level cadre of Wangcheng Economic Development Zone, the national level expert committee for the development of API industry in Wangcheng economic development zone was officially established, which will promote Hunan Pharmaceutical raw and auxiliary materials Industrial Park to be a high-end pharmaceutical raw and auxiliary materials Industrial Park with distinctive characteristics and great influence in the central region The expert committee is composed of Xi Zhenfeng, academician of the Chinese Academy of Sciences and professor of Peking University, Zhou Qilin, academician of the Chinese Academy of Sciences and professor of Nankai University, Xi Zhen, Changjiang Scholar and professor of Nankai University, Zhou Zhiping, executive director of the Research Institute of Tianshi group, Zeng Wenbin, vice president of Xiangya College of Central South University, Zhang Qinghua, chairman of Hunan Fangsheng Pharmaceutical Co., Ltd., and Dong of Hunan Huateng Pharmaceutical Co., Ltd Deng Zeping, President of the board of directors, Zheng Xiahui, general manager of Hunan Jiudian Pharmaceutical Co., Ltd., Ouyang Dongsheng, chairman of Changsha Duzheng Biotechnology Co., Ltd., Xu Hong, executive deputy general manager of Hunan Warner Pharmaceutical Co., Ltd., Wu Siqing, Dean of Hunan Huateng Pharmaceutical Co., Ltd., Zhu Yanfei, general manager of Chongqing Boyi Equity Investment Fund Management Co., Ltd., wangchengjing Zheng Yiren, deputy secretary of the Party Working Committee and director of the Management Committee of the Development Zone, issued a letter of appointment to the experts of the Committee △ Zheng Yiren, deputy secretary of the Party Working Committee and director of the Management Committee of Wangcheng Economic Development Zone, issues the letter of appointment to the Committee experts △ Zheng Yiren, deputy secretary of the Party Working Committee and director of the Management Committee of Wangcheng Economic Development Zone, issues the letter of appointment to the Committee experts △ Zheng Yiren, deputy secretary of the Party Working Committee and director of the Management Committee of Wangcheng Economic Development Zone, issues the letter of appointment to the Committee experts At the opening ceremony of the project signing to help the diversified development of the industry, Huateng pharmaceutical and its strategic partners held the project signing ceremony There are four projects in this contract, including pharmaceutical chemistry research, new drug crystal and drug targeted delivery, pharmaceutical innovation technology and artificial intelligence They are the new drug development platform based on artificial intelligence deuterium technology of American Jinglian Pharmaceutical Co., Ltd., the research and development of small molecule targeted anti-tumor innovative drugs of Shanghai Huali biomedical Co., Ltd., and Zhuhai The tumor immunotherapy innovative biological drug development of Danchi equity investment fund partnership (limited partnership), and the drug development project for the new target of liver cancer by Professor Yang Shengyong of Sichuan University △ project signing between Huateng pharmaceutical and its partners With the support of high-end innovative resources of biomedicine at home and abroad, Huateng Pharmaceutical Industrial Park, located in Wangcheng Economic Development Zone, will usher in new opportunities for development It is committed to building a comprehensive industrialization base integrating basic research, pharmaceutical research and achievements, forming the core competitiveness and industrial advantages of Huateng pharmaceutical technology, and seizing the war of long-term sustained-release technology and long-term sustained-release new drug industry A little commanding point will help to open a new chapter in the development of Changsha pharmaceutical industry 　　 Later, academician Xi Zhenfeng, academician Zhou Qilin, Professor Xi Zhen, chairman of Hunan Huateng Pharmaceutical Co., Ltd Deng Zeping, secretary and director of the Party group of Changsha Science and Technology Bureau, deputy secretary of the Party Working Committee and director of the Management Committee of Wangcheng Economic Development Zone, Zheng Yiren, member of the Party group of Changsha Bureau of industry and information technology, Ou Weibing, researcher of Changsha market supervision and Administration Bureau, jointly touched the opening ceremony of the forum The Third International Forum on long-term sustained release new drug research and development and 2019 Hunan Pharmaceutical raw and auxiliary materials Industrial Park (Changsha) investment cooperation forum officially kicked off As the organizer of this summit forum, Hunan Huateng Pharmaceutical Co., Ltd responds to the call of national pharmaceutical innovation technology system construction and encourages drug research and development, actively explores the frontier direction and innovation achievements in the field of biomedicine, and strives to build a leading product in China's pharmaceutical industry Deng Zeping, chairman of Hunan Huateng Pharmaceutical Co., Ltd., said: "the company is growing rapidly Thank you very much for the support of government leaders at all levels, the guidance of experts and professors, and the trust of investors and customers The company is committed to constantly striving for the cause of human medicine and health, and hopes to build a new drug R & D center in beautiful Hunan, beautiful Changsha and beautiful Wangcheng to make good drugs and benefit mankind through joint efforts After the company goes public, Huateng foundation will be established to better serve medical care and education " Disclaimer: This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprinting is to transmit more information and does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact with this website message, we will delete the content in the first time!